Kopp U C, Cicha M Z, Smith L A, Hökfelt T
Department of Internal Medicine, Department of Veterans Affairs Medical Center, Iowa City; University of Iowa College of Medicine, Iowa City, Iowa 52242, USA.
Am J Physiol Regul Integr Comp Physiol. 2001 Jul;281(1):R279-90. doi: 10.1152/ajpregu.2001.281.1.R279.
Nerve terminals containing neuronal nitric oxide synthase (nNOS) are localized in the renal pelvic wall where the sensory nerves containing substance P and calcitonin gene-related peptide (CGRP) are found. We examined whether nNOS is colocalized with substance P and CGRP. All renal pelvic nerve fibers that contained nNOS-like immunoreactivity (-LI) also contained substance P-LI and CGRP-LI. In anesthetized rats, renal pelvic perfusion with the nNOS inhibitor S-methyl-L-thiocitrulline (L-SMTC, 20 microM) prolonged the afferent renal nerve activity (ARNA) response to a 3-min period of increased renal pelvic pressure from 5 +/- 0.4 to 21 +/- 2 min (P < 0.01, n = 14). The magnitude of the ARNA response was unaffected by L-SMTC. Similar effects were produced by N(omega)-nitro-L-arginine methyl ester (L-NAME) but not D-NAME. Increasing renal pelvic pressure produced similar increases in renal pelvic release of substance P before and during L-SMTC, from 5.9 +/- 1.4 to 13.6 +/- 4.2 pg/min before and from 4.9 +/- to 12.6 +/- 2.7 pg/min during L-SMTC. L-SMTC also prolonged the ARNA response to renal pelvic perfusion with substance P (3 microM) from 1.2 +/- 0.2 to 5.6 +/- 1.1 min (P < 0.01, n = 9) without affecting the magnitude of the ARNA response.
activation of NO may function as an inhibitory neurotransmitter regulating the activation of renal mechanosensory nerve fibers by mechanisms related to activation of substance P receptors.
含有神经元型一氧化氮合酶(nNOS)的神经末梢定位于肾盂壁,此处可发现含有P物质和降钙素基因相关肽(CGRP)的感觉神经。我们研究了nNOS是否与P物质和CGRP共定位。所有含有nNOS样免疫反应性(-LI)的肾盂神经纤维也含有P物质-LI和CGRP-LI。在麻醉大鼠中,用nNOS抑制剂S-甲基-L-硫代瓜氨酸(L-SMTC,20 microM)进行肾盂灌注,使传入肾神经活动(ARNA)对肾盂压力增加3分钟的反应时间从5±0.4分钟延长至21±2分钟(P<0.01,n = 14)。ARNA反应的幅度不受L-SMTC影响。N(ω)-硝基-L-精氨酸甲酯(L-NAME)产生类似效果,但D-NAME则不然。增加肾盂压力在L-SMTC给药前和给药期间使肾盂P物质释放产生类似增加,从给药前的5.9±1.4 pg/min增加至13.6±4.2 pg/min,给药期间从4.9±增加至12.6±2.7 pg/min。L-SMTC还使ARNA对肾盂灌注P物质(3 microM)的反应时间从1.2±0.2分钟延长至5.6±1.1分钟(P<0.01,n = 9),而不影响ARNA反应的幅度。
NO的激活可能作为一种抑制性神经递质,通过与P物质受体激活相关的机制调节肾机械感觉神经纤维的激活。